JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 31, 2005; DOI: 10.1124/jpet.105.093641


0022-3565/05/3153-1196-1202$20.00
JPET 315:1196-1202, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.093641v1
315/3/1196    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuruppu, S.
Right arrow Articles by Hodgson, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuruppu, S.
Right arrow Articles by Hodgson, W. C.

NEUROPHARMACOLOGY

Isolation and Pharmacological Characterization of Cannitoxin, a Presynaptic Neurotoxin from the Venom of the Papuan Taipan (Oxyuranus scutellatus canni)

Sanjaya Kuruppu, Shane Reeve, Yajnavalka Banerjee, R. Manjunatha Kini, A. Ian Smith, and Wayne C. Hodgson

Monash Venom Group, Department of Pharmacology, Monash University, Victoria, Australia (S.K., W.C.H.); Department of Biochemistry and Molecular Biology, Monash University, Victoria, Australia (S.R., A.I.S.); and Department of Biological Sciences, Faculty of Science, National University of Singapore, Singapore, Singapore (Y.B., R.M.K.)

The Papuan taipan (Oxyuranus scutellatus canni) is widely distributed throughout much of Papua New Guinea. Although neurotoxicity is a major symptom of envenomation, no neurotoxins have been isolated from this venom. Using a series of size exclusion chromatography steps, we report the isolation of cannitoxin, a presynaptic neurotoxin (44,848 Da) that represents approximately 16% of the whole venom. The toxin displayed high phospholipase A2 (PLA2) activity (330 ± 5 µmol/min/mg) and caused concentration-dependent (11–66 nM) inhibition of indirect (0.2 ms; 0.1 Hz; supramaximal V) twitches of the chick biventer cervicis nerve-muscle preparation without effecting nicotinic receptor agonists. Prior addition of CSL Taipan antivenom (5 U/ml) or inhibition of phospholipase A2 activity by incubation with 4-bromophenacyl bromide prevented the inhibition of twitches. Cannitoxin is composed of three different subunits, {alpha}, {beta}, and {gamma}, with the possibility of two {beta} isomers. However, only the {alpha} subunit displayed in vitro neurotoxic activity of its own. Thus, cannitoxin is similar in structure and pharmacology to taipoxin, which has been isolated from the closely related Australian species O. scutellatus scutellatus (coastal taipan).


Received August 1, 2005; accepted August 30, 2005.

Address correspondence to: Dr. Wayne C. Hodgson. Monash Venom Group, Department of Pharmacology, Monash University, Victoria 3800, Australia. E-mail: wayne.hodgson{at}med.monash.edu.au







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.